SUNIL SAXENA: Open Payments
NPI 1346259637 · WHITE PLAINS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,071 in 42 payments from 11 companies in 2025. Trend: 2023 $859 · 2024 $1,106 · 2025 $1,071
Food & beverage: $1,071
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $348 |
| ABBVIE INC. | 10 | $211 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $173 |
| Neurocrine BioSciences, Inc. | 2 | $61 |
| Corium, LLC | 2 | $56 |
| Supernus Pharmaceuticals, Inc. | 2 | $55 |
| Indivior Inc. | 2 | $44 |
| Orexo US, Inc. | 2 | $43 |
| Braeburn Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
Products named: ARISTADA, VRAYLAR, CAPLYTA, VIVITROL, INGREZZA, Azstarys, Qelbree, SUBLOCADE.
Industry payments across NY — which companies pay providers there.
